Last update:

Immunology news

Oncology & Cancer

Lowering cancer drug dose could open tumors to immunotherapy

Research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the tumor's response to immunotherapy.

Immunology

Scientists discover proteins in meat, milk and other foods suppress gut tumors

Researchers led by Hiroshi Ohno at the RIKEN Center for Integrative medical sciences (IMS) in Japan have discovered that food antigens like milk proteins help keep tumors from growing in our guts, specifically the small intestines. ...

Oncology & Cancer

From new treatments to AI: advances in the fight against cancer

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new advances in the fight against cancer have been presented at the European Society for Medical Oncology ...

Oncology & Cancer

Reprogramming cancer cells to attack themselves

A team of health and medical researchers affiliated with a host of institutions across Sweden has tested the possibility of reprogramming cancer cells into cDC1 cells as a means for destroying the protective shield around ...

Immunology

Mucin gel may help disk herniation patients after surgery

Researchers at Uppsala University have developed a gel inspired by cow slime for patients suffering from disk herniation. By adding the mucin gel immediately after surgery, it is possible to create a protective barrier around ...

Diseases, Conditions, Syndromes

Neoself-antigens found to induce autoimmune response in lupus

Autoimmune diseases are widespread and notoriously difficult to treat. In part, this is because why the immune system attacks its own tissues in patients with these conditions remains poorly understood.

Oncology & Cancer

How the immune system fails as cancer arises

Cancer has been described as "a wound that does not heal," implying that the immune system is unable to wipe out invading tumor cells. A new discovery confirms that a key molecule can reprogram immune cells that normally ...

Oncology & Cancer

Tpex cells: A game-changer in targeted tumor immunotherapy

Progenitor exhausted CD8+ T (Tpex) cells have emerged as a pivotal component in tumor immunotherapy due to their unique ability to self-renew and rapidly proliferate. These cells have shown promise in expanding and differentiating ...

Oncology & Cancer

Drug bypasses suppressive immune cells to unleash immunotherapy

By recruiting the immune system to combat tumor cells, immunotherapy has improved survival rates, offering hope to millions of cancer patients. However, only about one in five people responds favorably to these treatments.

Oncology & Cancer

FDA approves engineered cell therapy for treating rare sarcoma

The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called ...

Oncology & Cancer

Overcoming the limits of immunotherapies

CAR-T cells are highly effective in treating selected blood cancers. However, challenges remain with this new therapy, which was first approved in 2017 in the U.S. and a year later in Europe for treating acute lymphoblastic ...